Active Not RecruitingNCT06864988
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
PHASE3 · 480 planned enrolment
- Countries listed
- 2
- Registry update
- June 1, 2026
immortal.lifeTrial registrations containing the exact intervention label 4D-150 IVT (3E10 vg/eye).
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE3 · 480 planned enrolment
PHASE3 · 480 planned enrolment